Skip to main content

Table 2 BBN cross-validation results for each train-and-test pair and a posteriori testing results

From: Development of a clinical decision model for thyroid nodules

  AUC PV @ 50% Cancer, At 50% Threshold Benign, At 50% Threshold
  Benign Cancer Benign Cancer Sensitivity Specificity Sensitivity Specificity
Test 1 71.4% 71.5% 60.0% 66.7% 66.8% 50.0% 60.0% 58.3%
Test 2 93.4% 93.4% 80.0% 81.8% 81.8% 70.0% 90.0% 81.7%
Test 3 89.2% 88.7% 81.3% 85.7% 66.8% 85.7% 92.9% 55.6%
Test 4 89.8% 89.1% 81.8% 66.7% 90.0% 69.2% 77.1% 80.0%
Test 5 92.1% 92.2% 77.8% 91.7% 92.4% 87.5% 87.6% 77.0%
Test 6 99.8% 99.8% 100.0% 100.0% 100.0% 91.6% 100.0% 77.8%
Test 7 76.0% 76.0% 80.0% 80.0% 90.0% 80.0% 80.0% 70.0%
Test 8 90.6% 90.5% 78.6% 85.7% 66.8% 83.3% 100.0% 33.3%
Test 9 89.8% 90.5% 80.0% 81.8% 81.8% 70.0% 90.0% 72.7%
Test 10 88.2% 88.2% 70.0% 91.7% 85.6% 87.5% 87.6% 28.6%
Mean 88.0% 88.0% 78.9% 83.2% 82.2% 77.5% 86.5% 63.5%
Internal 88.6% 89.0% 81.5% 82.6% 81.8% 81.3% 82.4% 81.0%